Works matching IS 14363291 AND DT 2020 AND VI 23 AND IP 1
Results: 24
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 95, doi. 10.1007/s10120-019-00999-9
- By:
- Publication type:
- Article
Convolutional neural network for the diagnosis of early gastric cancer based on magnifying narrow band imaging.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 126, doi. 10.1007/s10120-019-00992-2
- By:
- Publication type:
- Article
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 168, doi. 10.1007/s10120-019-00991-3
- By:
- Publication type:
- Article
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 160, doi. 10.1007/s10120-019-00990-4
- By:
- Publication type:
- Article
Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 195, doi. 10.1007/s10120-019-00989-x
- By:
- Publication type:
- Article
Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 82, doi. 10.1007/s10120-019-00988-y
- By:
- Publication type:
- Article
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 184, doi. 10.1007/s10120-019-00986-0
- By:
- Publication type:
- Article
Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 154, doi. 10.1007/s10120-019-00985-1
- By:
- Publication type:
- Article
Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 64, doi. 10.1007/s10120-019-00984-2
- By:
- Publication type:
- Article
IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 23, doi. 10.1007/s10120-019-00976-2
- By:
- Publication type:
- Article
A genetic origin for acid–base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 52, doi. 10.1007/s10120-019-00982-4
- By:
- Publication type:
- Article
Survival after neoadjuvant approaches to gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 175, doi. 10.1007/s10120-019-00980-6
- By:
- Publication type:
- Article
Correction to: Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E = G and GE cancers.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 39, doi. 10.1007/s10120-019-00977-1
- By:
- Publication type:
- Article
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 73, doi. 10.1007/s10120-019-00983-3
- By:
- Publication type:
- Article
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 143, doi. 10.1007/s10120-019-00970-8
- By:
- Publication type:
- Article
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 118, doi. 10.1007/s10120-019-00966-4
- By:
- Publication type:
- Article
Peritoneal metastasis in gastric cancer: results from the German database.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 11, doi. 10.1007/s10120-019-00978-0
- By:
- Publication type:
- Article
Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 3, doi. 10.1007/s10120-019-01022-x
- By:
- Publication type:
- Article
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A message from the new editor-in-chief.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 105, doi. 10.1007/s10120-019-01010-1
- By:
- Publication type:
- Article
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 133, doi. 10.1007/s10120-019-01008-9
- By:
- Publication type:
- Article